Holder Michael bought CTKB
November 18, 2025 · Form 4 insider transaction
Holder Michael bought 2,181 shares of Cytek Biosciences, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,181
Price
N/A
Total value
N/A
InsiderHolder Michael
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 18, 2025
Filing dateNovember 20, 2025
Shares owned after12,359
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.